GSK Investigational Site

San José

0 studies enrolling now · 9 studies all time

What they study most

Anxiety Disorders, Arthritis, Rheumatoid, Asthma, Diabetes Mellitus, Type 2, Epilepsy, Partial, HIV Infection, Infection, Human Immunodeficiency Virus I, Infections, Rotavirus, Rotavirus Vaccines, Schizophrenia, Skin Infections, Bacterial, Social Anxiety Disorder

Studies at this site

• Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks — Completed
• A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients — Completed
• Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
• SB-773812 Administered In Adults With Schizophrenia — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. — Completed
• A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma — Completed
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder — Completed